Leadership Overview
Frontage Laboratories has 5 executives leading key functions including strategy, operations, and finance.
Driven by scientific rigor, Frontage Laboratories is dedicated to accelerating drug development through integrated CRO services, enabling pharmaceutical and biotechnology partners to achieve critical regulatory milestones and bring life-changing therapies to market.
Driven by scientific rigor, Frontage Laboratories is dedicated to accelerating drug development through integrated CRO services, enabling pharmaceutical and biotechnology partners to achieve critical regulatory milestones and bring life-changing therapies to market.
Leadership Roles at Frontage Laboratories
Jonathan Lin - Co-Chief Executive Officer
Jonathan Lin, the Co-Chief Executive Officer at Frontage Laboratories, directs the overarching strategic vision and operational execution for the contract research organization. Lin guides the company's expansion into new therapeutic areas and geographic markets, ensuring Frontage Laboratories remains at the forefront of scientific innovation. This leadership role involves fostering key relationships with pharmaceutical and biotechnology partners, aligning service offerings with industry demands, and driving sustainable growth. Jonathan Lin's strategic direction ensures the company's integrated approach to drug discovery and development consistently meets client objectives and regulatory requirements across the United States, China, and beyond. The focus remains on enhancing the comprehensive suite of services, from early-phase clinical studies to manufacturing and bioanalysis, to expedite the journey of novel molecules through the development pipeline.
Daniella Kranjac - Co-Chief Executive Officer
Daniella Kranjac, the Co-Chief Executive Officer at Frontage Laboratories, spearheads the company's strategic initiatives and operational excellence. Kranjac focuses on enhancing the integrated service model, ensuring seamless delivery of drug discovery and development solutions to a global client base. This executive position involves cultivating strategic partnerships with pharmaceutical and biotechnology firms, driving innovation in service offerings, and optimizing resource allocation to meet evolving market needs. Daniella Kranjac's leadership ensures Frontage Laboratories consistently delivers high-quality scientific support, from preclinical safety assessments to clinical trial material manufacturing and bioanalysis. The objective is to empower clients to achieve their development goals efficiently, facilitating regulatory submissions and advancing critical therapeutic candidates through the pipeline.
Zhongping Lin - Co-Chief Executive Officer
Zhongping Lin, the Co-Chief Executive Officer at Frontage Laboratories, drives the strategic direction and operational framework for the contract research organization. Lin's leadership focuses on expanding the company's scientific capabilities and global reach, ensuring Frontage Laboratories provides comprehensive support throughout the drug development lifecycle. This executive role involves overseeing the integration of diverse services, including drug metabolism, pharmacokinetics, analytical testing, and clinical trial services, to offer a unified product development pathway. Zhongping Lin's commitment to scientific integrity and client success underpins the company's mission to accelerate the advancement of pharmaceutical and biotechnology innovations. The strategic imperative is to enhance operational efficiency and scientific rigor, enabling clients to navigate complex regulatory landscapes and bring novel treatments to patients worldwide.
Huan Wang - Interim Chief Financial Officer
Huan Wang, the Interim Chief Financial Officer at Frontage Laboratories, manages the company's financial operations and strategic fiscal planning. Wang oversees all aspects of financial reporting, budgeting, and resource management, ensuring the fiscal health and stability of the contract research organization. This executive position involves developing financial strategies that support Frontage Laboratories' growth objectives and operational expansion, particularly in its integrated drug discovery and development services. Huan Wang's financial oversight is crucial for maintaining investor confidence and enabling the company to invest in cutting-edge technologies and talent. The objective is to provide robust financial frameworks that facilitate the efficient advancement of pharmaceutical and biotechnology projects through regulatory approval and market entry.
Min Wang - Chief Operating Officer
Min Wang, the Chief Operating Officer at Frontage Laboratories, directs the day-to-day operational activities and ensures the efficient execution of integrated drug development services. Wang oversees the seamless functioning of various departments, including bioanalysis, preclinical safety, and clinical trial material manufacturing, to support pharmaceutical and biotechnology clients. This critical role involves optimizing laboratory processes, managing resource allocation, and implementing best practices to enhance productivity and quality across all service lines. Min Wang's operational leadership is essential for maintaining Frontage Laboratories' reputation for scientific excellence and timely project completion. The focus remains on streamlining workflows and fostering a culture of continuous improvement to accelerate the development of novel therapeutics from discovery through regulatory submission.
Explore Leadership Teams in Business Services
Fortrea is a global clinical research organization that specializes in navigating the complexities of clinical trials and research and development services. Founded in 2006, the company provides comprehensive clinical research solutions with a focus on scientific rigor and innovative problem-solving. Fortrea offers services that help transform promising medical ideas into proven therapies, supporting the entire clinical development process. With operations across North America, Europe, Asia Pacific, Africa, and South America, Fortrea serves clients in the pharmaceutical, biotechnology, and healthcare industries through its extensive network of research facilities and specialized teams.
Company Leadership
MR
PS
PB
The Association of Universities for Research in Astronomy operates as a nonprofit consortium of academic institutions and international partners dedicated to advancing observational astronomy through strategic management of major research facilities. The organization critical bridge between the scientific community and federal funding agencies, overseeing the operations of world-class astronomical research centers that enable transformative discoveries about the universe. Founded as a collaborative framework for universities to pool resources and expertise, the association has developed sophisticated operational models for managing complex astronomical observatories and research infrastructure. This institutional structure allows member universities to maintain scientific independence while benefiting from shared administrative capabilities, technical expertise, and access to cutting-edge instrumentation. The organization's governance model reflects a commitment to fostering collaborative research across institutional boundaries. AURA Astronomy directs operations of multiple astronomical research centers that serve the broader scientific community through telescope access, data management, and research support services. These facilities enable astronomers to conduct observations across multiple wavelengths and scales, from studying distant galaxies to examining stellar phenomena.
Company Leadership MM
CF
LC
Advarra advances the way clinical research is conducted: bringing life sciences companies, CROs, research sites, investigators, and academia together at the intersection of safety, technology, and collaboration. With trusted review solutions, innovative technologies, experienced consultants, and deep-seated connections across the industry, Advarra provides integrated solutions that safeguard trial participants, empower clinical sites, ensure compliance, and optimize research performance. Advarra is advancing clinical trials to make them safer, smarter, and faster.
Company Leadership GS
SU
The Chinese Academy of Sciences (CAS) is the highest academic institution in the field of science and technology in China, serving as a comprehensive research and development center for natural sciences and high-tech. Established in 1949, CAS focuses on original innovation, key core technology breakthroughs, and aims to contribute significantly to the nation's scientific advancement and economic development. It offers a range of services including scientific research, talent education, and technology transfer, targeting government agencies, educational institutions, and the general public. CAS is committed to building a high-level scientific research institution and fostering international collaboration in scientific endeavors.
Company Leadership CL
JP
PS
MS
Frequently Asked Questions Regarding Frontage Laboratories Top Executives and Leadership Team
